Neurology Grand Rounds

Walker Auditorium

Monday February 22, 2016 at 12:15 PM

Video-conferenced to Nemours 1 North & Mayo Clinic Health System in Waycross

Nilufer Ertekin-Taner, M.D., Ph.D., presents “Comparative –omics Studies in Alzheimer’s and Other Neurodegenerative Diseases”  at Neurology Grand Rounds 12:15 PM on February 22, 2016

 Nilufer Ertekin-Taner, M.D., Ph.D., is a neurogeneticist focused on the complex genetics of Alzheimer's disease (AD) and other neurodegenerative diseases. She is also a practicing board-certified neurologist with subspecialty training in behavioral neurology.

Dr. Ertekin-Taner's laboratory aims to discover and characterize the genetic factors that influence the risk of AD and other neurodegenerative diseases, such as progressive supranuclear palsy (PSP), through the use of combined genomic, transcriptomic and epigenetic approaches. Further, her laboratory utilizes biological traits such as cognition to study the downstream effects of genetic factors. Identification of genetic risk factors for AD in African-Americans and atypical forms of AD are additional ongoing projects in the laboratory.

Learning Objectives:

Define areas of new neuroscience knowledge and research

Understand Clinicopathologic (CPC) correlations of neurologic disease

Illuminate areas of practice-based improvement within the neurosciences based on advancing scientific research or Practice-based improvement projects.

The speaker does not have a relevant financial relationship, and does not intend to discuss off label/investigative use of a commercial product or device.

College of Medicine, Mayo Clinic, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

College of Medicine, Mayo Clinic, designates this live CME activity for a maximum of 1.0 AMA PRA Category 1 Credits^RM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is supported in part by an educational grant from the following companies in accordance with ACCME Standards:  NONE